594 related articles for article (PubMed ID: 14648456)
1. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
[TBL] [Abstract][Full Text] [Related]
2. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America--the Argentinean case.
Rossi D; Goltzman P; Cymerman P; Touzé G; Weissenbacher M
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S362-5. PubMed ID: 14648448
[TBL] [Abstract][Full Text] [Related]
4. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
[TBL] [Abstract][Full Text] [Related]
5. AIDS and the social relations of intravenous drug users.
Friedman SR; Des Jarlais DC; Sterk CE; Sotheran JL; Tross S; Woods J; Sufian M; Abdul-Quader A
Milbank Q; 1990; 68 Suppl 1():85-110. PubMed ID: 2381380
[TBL] [Abstract][Full Text] [Related]
6. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
7. Obstacles to the development of prevention and public health policies in Argentina.
Touzé G
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
[TBL] [Abstract][Full Text] [Related]
8. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
Inchaurraga S
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus and the substance abuser: public policy considerations.
Ruiz P; Fernandez F
Tex Med; 1994 May; 90(5):64-7. PubMed ID: 8029770
[TBL] [Abstract][Full Text] [Related]
10. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
[TBL] [Abstract][Full Text] [Related]
11. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
12. HIV/AIDS: Latin America & Caribbean. Puerto Rico: rich port, poor port.
Cohen J
Science; 2006 Jul; 313(5786):475-6. PubMed ID: 16873644
[No Abstract] [Full Text] [Related]
13. Economic aspect of HIV/AIDS control and injecting drug use in Indonesia.
Siregar AY; Komarudin D; Leuwol B; Afriandi I; Djuhaeni H; Baltussen R
Acta Med Indones; 2009 Jul; 41 Suppl 1():70-4. PubMed ID: 19920302
[TBL] [Abstract][Full Text] [Related]
14. The challenge of implementation of preventive programs in a developing country: experiences, situations, and perspectives in Uruguay.
Osimani ML
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S422-6. PubMed ID: 14648458
[TBL] [Abstract][Full Text] [Related]
15. Rapid scale up of harm reduction in China.
Sullivan SG; Wu Z
Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
[TBL] [Abstract][Full Text] [Related]
16. The HIV/AIDS epidemic in China: history, current strategies and future challenges.
Wu Z; Rou K; Cui H
AIDS Educ Prev; 2004 Jun; 16(3 Suppl A):7-17. PubMed ID: 15262561
[TBL] [Abstract][Full Text] [Related]
17. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
De Castro S; Sabaté E
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
[TBL] [Abstract][Full Text] [Related]
18. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
19. Injection drug use and HIV/AIDS transmission in China.
Chu TX; Levy JA
Cell Res; 2005; 15(11-12):865-9. PubMed ID: 16354561
[TBL] [Abstract][Full Text] [Related]
20. Failed drug policies in the United States and the future of AIDS: a perfect storm.
Drucker E
J Public Health Policy; 2012 Aug; 33(3):309-16. PubMed ID: 22895500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
